Skip to content
TrialScanner

NCT00284986

Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

Phase 2CompletedMESOLead

Registry record

Lead sponsor
Mesoblast, Inc.
Conditions
Graft Versus Host Disease
Primary completion
Apr 25, 2006Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00284986 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00284986: Safety and Efficacy of... | TrialScanner